Skip to main content
Swing Capital

Indo US Bio-Tech Ltd

NSE: INDOUS BSE: 541304

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]

₹103
52W: ₹95 — ₹206
PE 13.9 · Book ₹43.2 · +138% vs book
Market Cap₹206 Cr
Stock P/E13.9Price to Earnings
ROCE21.2%Return on Capital
ROE23%Return on Equity
Div. Yield0.24%Face Value ₹10

Strengths

  • +Company is expected to give good quarter
  • +Company has delivered good profit growth of 45.0% CAGR over last 5 years
  • +Debtor days have improved from 98.9 to 52.7 days.
  • +Company's median sales growth is 20.7% of last 10 years

Weaknesses

  • −Promoter holding has decreased over last quarter: -1.88%
  • −Tax rate seems low
  • −Company might be capitalizing the interest cost

Shareholding Pattern

Promoters68.29%
FIIs0.18%
DIIs0%
Public31.53%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters70.18%70.18%70.18%70.18%70.18%70.18%70.18%68.29%▼1.9
FIIs0%0%0%0%0%0%0%0.18%▲0.2
DIIs0%0%0%0%0%0%0%0%
Public29.82%29.83%▲0.029.82%▼0.029.83%▲0.029.83%29.83%29.83%31.53%▲1.7

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales15.8122.1115.7724.7222.1723.5633.3830.7730.8522.8
Expenses13.2117.8814.7921.0317.0518.0228.825.326.6918.65
Operating Profit2.64.230.983.695.125.544.585.474.164.15
OPM %16.45%19.13%6.21%14.93%23.09%23.51%13.72%17.78%13.48%18.2%
Net Profit1.673.680.523.174.365.053.684.73.453
EPS ₹0.831.840.261.582.172.521.842.341.721.5

AI Insights

Revenue Trend

TTM revenue at ₹118Cr, up 13.5% YoY. OPM at 16%.

Debt Position

Borrowings at ₹28Cr. Debt-to-equity ratio: 0.42x. Healthy balance sheet.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0.18% (+0.18pp change). Promoters hold 68.29%.

Margin & Efficiency

ROCE improving from 9% (Mar 2014) to 21% (Mar 2025). Working capital days: 247.

Valuation

PE 13.9x with 21.2% ROCE. Price is 138% above book value of ₹43.2. Dividend yield: 0.24%.

Recent Announcements